Literature DB >> 21505959

Different factor H-related protein patterns in siblings with typical hemolytic uremic syndrome.

Marcus R Benz, Holger Schmid, Stefan Heinen, Bärbel Lange-Sperandio, Julia Hoefele, Thomas Sitter, Peter F Zipfel, Lutz T Weber.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21505959     DOI： 10.1007/s00467-011-1885-y

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN： 0931-041X            Impact factor:   3.714


× No keyword cloud information.
  7 in total

1.  Epidemiology, clinical presentation, and pathophysiology of atypical and recurrent hemolytic uremic syndrome.

Authors:  L Bernd Zimmerhackl; Nesir Besbas; Therese Jungraithmayr; Nicole van de Kar; Helge Karch; Diana Karpman; Daniel Landau; Chantal Loirat; Willem Proesmans; Friederike Prüfer; Gianfranco Rizzoni; Mark C Taylor
Journal:  Semin Thromb Hemost       Date:  2006-03       Impact factor: 4.180

2.  Effects of complement regulators bound to Escherichia coli K1 and Group B Streptococcus on the interaction with host cells.

Authors:  Ravi Maruvada; Anna M Blom; Nemani V Prasadarao
Journal:  Immunology       Date:  2007-11-20       Impact factor: 7.397

3.  Factor H autoantibodies in atypical hemolytic uremic syndrome correlate with CFHR1/CFHR3 deficiency.

Authors:  Mihály Józsi; Christoph Licht; Stefanie Strobel; Svante L H Zipfel; Heiko Richter; Stefan Heinen; Peter F Zipfel; Christine Skerka
Journal:  Blood       Date:  2007-11-15       Impact factor: 22.113

4.  Clustering of post-diarrheal (Shiga toxin-mediated) hemolytic uremic syndrome in families.

Authors:  R L Siegler; J R Sherbotie; N D Denkers; A T Pavia
Journal:  Clin Nephrol       Date:  2003-08       Impact factor: 0.975

5.  Clinical practice guidelines for the management of atypical haemolytic uraemic syndrome in the United Kingdom.

Authors:  C Mark Taylor; Sam Machin; Stephen J Wigmore; Tim H J Goodship
Journal:  Br J Haematol       Date:  2009-10-11       Impact factor: 6.998

6.  Factor H-related protein 1 (CFHR-1) inhibits complement C5 convertase activity and terminal complex formation.

Authors:  Stefan Heinen; Andrea Hartmann; Nadine Lauer; Ulrike Wiehl; Hans-Martin Dahse; Sylvia Schirmer; Katharina Gropp; Tina Enghardt; Reinhard Wallich; Steffi Hälbich; Michael Mihlan; Ursula Schlötzer-Schrehardt; Peter F Zipfel; Christine Skerka
Journal:  Blood       Date:  2009-06-15       Impact factor: 22.113

7.  Deletion of complement factor H-related genes CFHR1 and CFHR3 is associated with atypical hemolytic uremic syndrome.

Authors:  Peter F Zipfel; Matthew Edey; Stefan Heinen; Mihály Józsi; Heiko Richter; Joachim Misselwitz; Bernd Hoppe; Danny Routledge; Lisa Strain; Anne E Hughes; Judith A Goodship; Christoph Licht; Timothy H J Goodship; Christine Skerka
Journal:  PLoS Genet       Date:  2007-02-01       Impact factor: 5.917
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.